imidazole has been researched along with Leishmaniasis, Visceral in 3 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mesquita, JT | 1 |
| da Costa-Silva, TA | 1 |
| Borborema, SE | 1 |
| Tempone, AG | 1 |
| Sánchez-Moreno, M | 1 |
| Gómez-Contreras, F | 1 |
| Navarro, P | 1 |
| Marín, C | 1 |
| Ramírez-Macías, I | 1 |
| Rosales, MJ | 1 |
| Campayo, L | 1 |
| Cano, C | 1 |
| Sanz, AM | 1 |
| Yunta, MJ | 1 |
| Pandey, RK | 1 |
| Sharma, D | 1 |
| Bhatt, TK | 1 |
| Sundar, S | 1 |
| Prajapati, VK | 1 |
3 other studies available for imidazole and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Activity of imidazole compounds on Leishmania (L.) infantum chagasi: reactive oxygen species induced by econazole.
Topics: Antiprotozoal Agents; Cell Membrane; Cell Membrane Permeability; Clotrimazole; Econazole; Imidazoles | 2014 |
Imidazole-containing phthalazine derivatives inhibit Fe-SOD performance in Leishmania species and are active in vitro against visceral and mucosal leishmaniasis.
Topics: Animals; Enzyme Inhibitors; Female; Humans; Imidazoles; Leishmania; Leishmania braziliensis; Leishma | 2015 |
Developing imidazole analogues as potential inhibitor for Leishmania donovani trypanothione reductase: virtual screening, molecular docking, dynamics and ADMET approach.
Topics: Antiprotozoal Agents; Catalytic Domain; Drug Discovery; Enzyme Inhibitors; Host-Parasite Interaction | 2015 |